We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$18.6B
AUM Growth
-$1.59B
Cap. Flow
-$881M
Cap. Flow %
-4.75%
Top 10 Hldgs %
25.83%
Holding
430
New
84
Increased
94
Reduced
203
Closed
27

Top Buys

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$241M
2
TWLO icon
Twilio
TWLO
+$60M
3
XYZ
Block Inc
XYZ
+$50.5M
4
BBIO icon
BridgeBio Pharma
BBIO
+$50M
5
SOFI icon
SoFi Technologies
SOFI
+$45.9M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$398M
2
ROKU icon
Roku
ROKU
+$137M
3
MTCH icon
Match Group
MTCH
+$117M
4
GS icon
Goldman Sachs
GS
+$107M
5
ENPH icon
Enphase Energy
ENPH
+$96M

Sector Composition

Rank Sector Weight
1 Technology 26.52%
2 Healthcare 23.41%
3 Consumer Discretionary 18.52%
4 Communication Services 12.03%
5 Miscellaneous 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSK icon
51
Autodesk
ADSK
$47.8B
$106M 0.57%
382,940
-143,223
-27% -$41.3M
ARVN icon
52
Arvinas
ARVN
$549M
$105M 0.57%
1,588,528
-167,594
-10% -$12.8M
STNE icon
53
StoneCo
STNE
$2.33B
$99.4M 0.54%
1,623,913
+2,569
+0.2% +$200K
ADPT icon
54
Adaptive Biotechnologies
ADPT
$3.86B
$96M 0.52%
2,384,205
+9,407
+0.4% +$509K
SMG icon
55
ScottsMiracle-Gro
SMG
$3.26B
$93.8M 0.51%
382,903
+3,498
+0.9% +$792K
GLOB icon
56
Globant
GLOB
$1.63B
$93.2M 0.5%
449,048
-109,232
-20% -$23.2M
WSO icon
57
Watsco Inc
WSO
$13B
$93M 0.5%
356,802
-9,263
-3% -$2.28M
PINS icon
58
Pinterest
PINS
$11.2B
$92.9M 0.5%
1,254,532
+12,974
+1% +$965K
RGEN icon
59
Repligen
RGEN
$9.48B
$91M 0.49%
467,899
-12,726
-3% -$2.61M
BYND icon
60
Beyond Meat
BYND
$177M
$89.3M 0.48%
22,882
-93
-0.4% -$410K
ACCD
61
DELISTED
Accolade Inc
ACCD
$86.1M 0.46%
1,897,161
+290,660
+18% +$14M
TAL icon
62
TAL Education Group
TAL
$6.55B
$85M 0.46%
1,578,127
+1,619
+0.1% +$119K
DXCM icon
63
DexCom
DXCM
$31.3B
$84.9M 0.46%
945,088
-78,104
-8% -$7.33M
ASAN icon
64
Asana
ASAN
$2.21B
$84.5M 0.46%
2,957,059
-68,989
-2% -$2.38M
GOOGL icon
65
Alphabet (Google) Class A
GOOGL
$4.27T
$80.5M 0.43%
780,540
-16,220
-2% -$1.6M
SIBN icon
66
SI-BONE Inc
SIBN
$838M
$78.6M 0.42%
2,471,701
-115,374
-4% -$3.55M
RNLX
67
DELISTED
Renalytix plc American Depositary Shares
RNLX
$77.5M 0.42%
3,021,317
+470,577
+18% +$11.8M
MSFT icon
68
Microsoft
MSFT
$3.75T
$70.9M 0.38%
300,878
+15,292
+5% +$3.55M
GKOS icon
69
Glaukos
GKOS
$10.1B
$70.9M 0.38%
844,379
-33,344
-4% -$2.93M
VLRS
70
Controladora Vuela Compania de Aviacion
VLRS
$749M
$70.3M 0.38%
4,929,829
+191,951
+4% +$2.6M
RLAY icon
71
Relay Therapeutics
RLAY
$4.14B
$69.8M 0.38%
2,020,461
-46,470
-2% -$2.02M
ETSY icon
72
Etsy
ETSY
$6.83B
$69.4M 0.37%
343,909
-606
-0.2% -$127K
API
73
Agora
API
$343M
$69.3M 0.37%
1,379,315
+606,094
+78% +$38.2M
TNDM icon
74
Tandem Diabetes Care
TNDM
$1.17B
$69M 0.37%
781,459
-609,058
-44% -$56.6M
SILV
75
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$66.6M 0.36%
8,243,395
-143,471
-2% -$1.31M

Similar funds

Gilder Gagnon Howe & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Gilder Gagnon Howe & Co held 430 positions worth $18.6B, down 7.9% from $20.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $881M in Q1 2021, closing 27 positions and reducing 203 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Affirm worth $175M.

  • Gilder Gagnon Howe & Co's largest Q1 2021 buy was Affirm: 2,479,834 shares worth $175M.
  • Gilder Gagnon Howe & Co added most to Twilio in Q1 2021, an estimated $60M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2021 reduction was Tesla, cutting an estimated $398M.
  • Gilder Gagnon Howe & Co fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $43.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $18.6B portfolio in Q1 2021.
  • Gilder Gagnon Howe & Co opened 84 new positions and closed 27 in Q1 2021.
  • Gilder Gagnon Howe & Co's portfolio value fell 7.9% quarter-over-quarter to $18.6B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2021, filed 17 May 2021.